Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 7 Colonic Neoplasms 6 Colonic Polyps 4 Inflammatory Bowel Diseases 3 Surgical Wound Infection 2 Rectal Neoplasms 2 Neoplasms 2 Melanoma 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Sarcoma 1 Polyps 1 Ovarian Neoplasms 1 Opioid-Induced Constipation 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Intestinal Neoplasms 1 Gastrointestinal Hemorrhage 1 Diverticulitis 1 Colonic Diseases 1 Cancer Pain 1 Adenoma 1

Interventions

Colonoscopy 8 Endoscopy 3 Narrow Band Imaging 2 Eicosapentaenoic Acid 2 eicosapentaenoic acid ethyl ester 1 Uterine Myomectomy 1 Ursodeoxycholic Acid 1 Telemedicine 1 Suppositories 1 Sennosides 1 Selenium 1 Restraint, Physical 1 Radiotherapy 1 Propofol 1 Polyethylene Glycols 1 Ofloxacin 1 Midazolam 1 Metoclopramide 1 Methods 1 Folic Acid 1 Fentanyl 1 Fatty Acids, Omega-3 1 Everolimus 1 Erythromycin 1 Endoscopic Mucosal Resection 1 Endomet 1 Doxycycline 1 Docosahexaenoic Acids 1 Diet, Fat-Restricted 1 Diet 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Polyps × Polyethylene Glycols × Clear all

NCT02893748 2019-09-23

HyGIeaCare Prep vs Split-dose PEG Prep Prior to Colonoscopy

HyGIeaCare, Inc.

Phase NA Withdrawn

Neoplasms, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon ⚡